Phase I study of the novel distamycin derivative tallimustine (FCE 24517)

Annals of Oncology

Volumn 5, Issue 10, 1994, Pages 901-907

  Sessa, C ^a   Pagani, O ^a   Zurlo, M G ^b   De Jong, J ^a   Hofmann, C ^a   Lassus, M ^b   Marrari, P ^b   Strolin Benedetti, M ^b   Cavalli, F ^a  

^a OSPEDALE SAN GIOVANNI   (Switzerland)

^b PFIZER INC   (United States)

Author keywords

Alkylating agents; DNA minor groove binders; Phase I; Tallimustine

Indexed keywords

ALKYLATING AGENT; TALLIMUSTINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOLID TUMOR;

ADULT; AGED; ANTINEOPLASTIC AGENTS; DISTAMYCINS; FEMALE; HUMAN; MALE; MIDDLE AGE; NEOPLASMS; NEUTROPENIA; NITROGEN MUSTARD COMPOUNDS; REMISSION INDUCTION;

EID: 0028597070     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.annonc.a058728     Document Type: Article

References (0)